Clindamycin Phosphate
C18H34ClN2O8PS
504.96
l-threo-α-d-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-;
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-α-d-galacto-octopyranoside 2-(dihydrogen phosphate) [24729-96-2]
l-threo-α-d-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-;
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-α-d-galacto-octopyranoside 2-(dihydrogen phosphate) [24729-96-2]
DEFINITION
Clindamycin Phosphate has a potency equivalent to NLT 758 µg/mg of clindamycin (C18H33ClN2O5S), calculated on the anhydrous basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Clindamycin Phosphate RSUSP Clindamycin Phosphate System Suitability RS